Clinical Evaluation of Extracellular ADMA Concentrations in Human Blood and Adipose Tissue

Circulating asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, has been proposed as a biomarker for clinical outcome. Dimethylarginine dimethylaminohydrolase (DDAH) is the main enzyme responsible for ADMA metabolism and elimination. Adipose tissue ADMA concentra...

Descripción completa

Detalles Bibliográficos
Autores principales: May, Marcus, Batkai, Sandor, Zörner, Alexander A., Tsikas, Dimitrios, Jordan, Jens, Engeli, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2014
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907863/
https://www.ncbi.nlm.nih.gov/pubmed/24445256
http://dx.doi.org/10.3390/ijms15011189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907863/
https://www.ncbi.nlm.nih.gov/pubmed/24445256
http://dx.doi.org/10.3390/ijms15011189

Ejemplares similares